Bioidentical Hormones: What the Evidence Shows

"Bioidentical" hormones are widely marketed, and the term can mean very different things. This page summarises, in plain language, what major guidelines and the broad body of evidence indicate, and where popular claims run ahead of the research.

What "bioidentical" actually means

"Bioidentical" generally refers to hormones that are chemically identical to those the human body makes. Importantly, many regulated, prescription hormone products already meet that description, and they are made to consistent standards and studied for quality. The term is often used in marketing, however, to suggest something distinct and inherently safer, which is where the evidence and the messaging can diverge.

A separate category is custom-compounded preparations, mixed by a pharmacy to an individual recipe. These are different from standardised, regulated products, and major organisations have raised specific concerns about them, as discussed below.

What the evidence broadly supports

The broad body of research and major guidelines support that hormone therapy, including regulated products that are chemically identical to the body's own hormones, can be appropriate for specific situations such as managing bothersome menopausal symptoms in suitable people. Where regulated bioidentical products have been studied, they are considered alongside other hormone therapies, with benefits and risks weighed for each person. The general principle from guideline bodies is that the decision depends on the individual rather than on whether a hormone is labelled "bioidentical."

Where popular claims outrun the evidence

Marketing often presents compounded bioidentical hormones as safer, more natural, or more precisely tailored than standard prescription products. Major endocrine and menopause organisations have stated that high-quality evidence does not support these claims, and that compounded products are not subject to the same oversight for consistency and purity. Claims that hormone levels can be finely tuned to an individual using saliva testing or single blood measurements are also not well supported, because hormone levels naturally fluctuate and are difficult to interpret in isolation.

Where research is still developing

Open questions include how different formulations and routes of delivery compare over the long term, and how best to individualise therapy within evidence-based limits. For related background, see our treatments, hormones, and conditions sections, and other overviews in the studies index. The peer-reviewed literature can be explored through PubMed.